Editas Medicine (EDIT) Asset Utilization Ratio (2016 - 2025)
Editas Medicine's (EDIT) quarterly Asset Utilization Ratio came in at 0.22 in Q3 2025, up 29.75% year-on-year from 0.17 in Q3 2024, and up 37.13% on a QoQ basis from 0.16 in Q2 2025.
Editas Medicine (EDIT) Asset Utilization Ratio (2016 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 10 years of Asset Utilization Ratio data on file, last reported at 0.22 in Q3 2025.
- On a quarterly basis, Asset Utilization Ratio rose 29.75% year-over-year to 0.22 in Q3 2025; TTM through Sep 2025 was 0.22, a 29.75% increase from a year earlier, with the FY2024 full-year figure at 0.08, down 50.14% from the prior year.
- Asset Utilization Ratio for Q3 2025 stood at 0.22, up from 0.16 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for EDIT reached as high as 0.22 in Q3 2025 and fell as low as 0.03 in Q3 2021.
- Historically, Asset Utilization Ratio has averaged 0.1 across 5 years, with a median of 0.1 in 2024.
- Across the five-year window, Asset Utilization Ratio sank 77.26% in 2021 and surged 323.12% in 2024, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.04 in 2021, then climbed by 2.94% to 0.04 in 2022, then surged by 312.75% to 0.16 in 2023, then sank by 37.95% to 0.1 in 2024, then jumped by 132.95% to 0.22 in 2025.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.22 in Q3 2025, 0.16 in Q2 2025, and 0.12 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.10 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.15 |
| Dec 31, 2023 | 0.16 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.05 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.03 |
| Jun 30, 2021 | 0.11 |
| Mar 31, 2021 | 0.14 |
| Dec 31, 2020 | 0.16 |